{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T06:11:20Z","timestamp":1784182280887,"version":"3.55.0"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>APOBEC cytidine deaminases generate characteristic TCW-context mutations that diversify cancer genomes, yet their functional impact on colorectal cancer (CRC) progression and the tumor microenvironment (TME) remains poorly defined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We integrated whole-exome sequencing, bulk and single-cell transcriptomics from multi-cohort datasets, supported by functional assays and\n                      <jats:italic>in vivo<\/jats:italic>\n                      xenograft models, to delineate the biological and clinical consequences of APOBEC activation in CRC. A machine-learning framework was used to derive an APOBEC activation\u2013associated transcriptional signature (AAS).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Across multi-cohort datasets, AAS defined a colorectal cancer subtype with enriched TCW mutagenesis and significantly worse survival. High AAS tumors were associated with coordinated remodeling of the TME, including increased fibroblast and endothelial signatures and reduced cytotoxic immune infiltration. Single-cell analyses suggested that high AAS tumors were enriched for endothelial states with arterial and pro-angiogenic features. Conditioned-medium experiments further supported a potential tumor cell secretome-mediated link between APOBEC3B activation and endothelial transcriptional remodeling. Integrative analyses identified PCDH9 as a candidate APOBEC-associated target linked to Hippo, Wnt\/\u03b2-catenin, and TGF-\u03b2 signaling alterations, while mutation-specific causality remains to be experimentally validated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This multi-omics study identifies APOBEC activity as a central orchestrator of CRC evolution, associated with stromal-vascular remodeling and intracellular oncogenic activation through PCDH9-associated signaling alterations. The AAS provides a robust prognostic biomarker and highlights APOBEC-high tumors as candidates for anti-angiogenic therapy and for interventions targeting APOBEC-induced signaling vulnerabilities.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1835351","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T05:40:30Z","timestamp":1784180430000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of APOBEC mutagenesis with stromal and endothelial niche remodeling and PCDH9-linked signaling alterations in colorectal cancer"],"prefix":"10.3389","volume":"17","author":[{"given":"Junting","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Clinical Epidemiology and Evidence-based Medicine, The First Hospital of China Medical University","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaming","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Clinical Epidemiology and Evidence-based Medicine, The First Hospital of China Medical University","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baosen","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Clinical Epidemiology and Evidence-based Medicine, The First Hospital of China Medical University","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianshuang","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, The First Hospital of China Medical University","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Clinical Epidemiology and Evidence-based Medicine, The First Hospital of China Medical University","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.09.042","article-title":"Universal patterns of selection in cancer and somatic tissues","volume":"171","author":"Martincorena","year":"2017","journal-title":"Cell"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2021108389","article-title":"Cancer evolution: Darwin and beyond","volume":"40","author":"Vendramin","year":"2021","journal-title":"EMBO J"},{"key":"B4","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13073-023-01217-z","article-title":"Sequence dependencies and mutation rates of localized mutational processes in cancer","volume":"15","author":"Poulsgaard","year":"2023","journal-title":"Genome Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.cd-23-1510","article-title":"Cell states in cancer: drivers, passengers, and trailers","volume":"14","author":"Gargiulo","year":"2024","journal-title":"Cancer Discov"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1200\/jco.23.02668","article-title":"Tyrosine kinase inhibitors with and without up-front stereotactic radiosurgery for brain metastases from EGFR and ALK oncogene-driven non-small cell lung cancer (TURBO-NSCLC)","volume":"42","author":"Pike","year":"2024","journal-title":"J Clin Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02717-6","article-title":"Sotorasib with panitumumab in chemotherapy-refractory KRAS(G12C)-mutated colorectal cancer: a phase 1b trial","volume":"30","author":"Kuboki","year":"2024","journal-title":"Nat Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/s12943-024-02173-x","article-title":"Co-occurring mutations identify prognostic subgroups of microsatellite stable colorectal cancer","volume":"23","author":"Nunes","year":"2024","journal-title":"Mol Cancer"},{"key":"B9","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/s42003-025-07822-5","article-title":"Comprehensive genomic dependency landscape of a human colon cancer organoid","volume":"8","author":"Khalili","year":"2025","journal-title":"Commun Biol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s12943-021-01441-4","article-title":"Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer","volume":"20","author":"Zhu","year":"2021","journal-title":"Mol Cancer"},{"key":"B11","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/35094067","article-title":"APC, signal transduction and genetic instability in colorectal cancer","volume":"1","author":"Fodde","year":"2001","journal-title":"Nat Rev Cancer"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-021-00583-1","article-title":"High prevalence of TP53 loss and whole-genome doubling in early-onset colorectal cancer","volume":"53","author":"Kim","year":"2021","journal-title":"Exp Mol Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-020-0674-6","article-title":"DNA mismatch repair promotes APOBEC3-mediated diffuse hypermutation in human cancers","volume":"52","author":"Mas-Ponte","year":"2020","journal-title":"Nat Genet"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.cd-15-0344","article-title":"APOBEC enzymes: mutagenic fuel for cancer evolution and heterogeneity","volume":"5","author":"Swanton","year":"2015","journal-title":"Cancer Discov"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-genet-072920-035840","article-title":"APOBEC-induced mutagenesis in cancer","volume":"56","author":"Mertz","year":"2022","journal-title":"Annu Rev Genet"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gky1015","article-title":"COSMIC: the catalogue of somatic mutations in cancer","volume":"47","author":"Tate","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.18632\/oncoscience.155","article-title":"AID\/APOBEC deaminases and cancer","volume":"2","author":"Rebhandl","year":"2015","journal-title":"Oncoscience"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibs.2016.05.001","article-title":"The APOBEC protein family: united by structure, divergent in function","volume":"41","author":"Salter","year":"2016","journal-title":"Trends Biochem Sci"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-10-2607","article-title":"A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients","volume":"70","author":"Roessler","year":"2010","journal-title":"Cancer Res"},{"key":"B20","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/s41586-023-06303-1","article-title":"Therapy-induced APOBEC3A drives evolution of persistent cancer cells","volume":"620","author":"Isozaki","year":"2023","journal-title":"Nature"},{"key":"B21","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41389-022-00411-9","article-title":"Aberrant APOBEC3C expression induces characteristic genomic instability in pancreatic ductal adenocarcinoma","volume":"11","author":"Qian","year":"2022","journal-title":"Oncogenesis"},{"key":"B22","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13073-024-01362-z","article-title":"Spatial intra-tumour heterogeneity and treatment-induced genomic evolution in oesophageal adenocarcinoma: implications for prognosis and therapy","volume":"16","author":"Brosda","year":"2024","journal-title":"Genome Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"989","DOI":"10.3390\/ijms26030989","article-title":"Deaminase-driven reverse transcription mutagenesis in oncogenesis: critical analysis of transcriptional strand asymmetries of single base substitution signatures","volume":"26","author":"Steele","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.21147\/j.issn.1000-9604.2025.02.02","article-title":"Genomic spectra of lymphovascular invasion in breast cancer","volume":"37","author":"Shen","year":"2025","journal-title":"Chin J Cancer Res"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.xgen.2024.100528","article-title":"Whole-genome mapping of APOBEC mutagenesis in metastatic urothelial carcinoma identifies driver hotspot mutations and a novel mutational signature","volume":"4","author":"Nakauma-Gonzalez","year":"2024","journal-title":"Cell Genom"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2023.100933","article-title":"Mutational signatures and their association with survival and gene expression in urological carcinomas","volume":"44","author":"Karihtala","year":"2023","journal-title":"Neoplasia"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-022-01296-5","article-title":"APOBEC mutagenesis is a common process in normal human small intestine","volume":"55","author":"Wang","year":"2023","journal-title":"Nat Genet"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.34402","article-title":"Clinical and genomic characterization of mutational signatures across human cancers","volume":"152","author":"Liao","year":"2023","journal-title":"Int J Cancer"},{"key":"B29","doi-asserted-by":"publisher","first-page":"989","DOI":"10.3390\/v14092077","article-title":"Quantification of APOBEC3 mutation rates affecting the VP1 gene of BK polyomavirus in vivo","volume":"14","author":"McIlroy","year":"2022","journal-title":"Viruses"},{"key":"B30","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12915-022-01316-0","article-title":"APOBEC3 mutational signatures are associated with extensive and diverse genomic instability across multiple tumour types","volume":"20","author":"Jakobsdottir","year":"2022","journal-title":"BMC Biol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1186\/s12931-021-01871-0","article-title":"Mutational signature analysis in non-small cell lung cancer patients with a high tumor mutational burden","volume":"22","author":"van den Heuvel","year":"2021","journal-title":"Respir Res"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1158\/2767-9764.crc-24-0442","article-title":"APOBEC3 activity promotes the survival and evolution of drug-tolerant persister cells during EGFR inhibitor resistance in lung cancer","volume":"5","author":"Garcia","year":"2025","journal-title":"Cancer Res Commun"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1093\/narcan\/zcab005","article-title":"Molecular correlates of immune cytolytic subgroups in colorectal cancer by integrated genomics analysis","volume":"3","author":"Roufas","year":"2021","journal-title":"NAR Cancer"},{"key":"B34","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s12032-025-03056-x","article-title":"The dual role of PCDH9 in tumors, neurological and developmental diseases","volume":"42","author":"Li","year":"2025","journal-title":"Med Oncol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctarc.2025.100872","article-title":"The emerging role of blood-based biomarkers in early detection of colorectal cancer: a systematic review","volume":"42","author":"Shweikeh","year":"2024","journal-title":"Cancer Treat Res Commun"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1835351\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T05:40:31Z","timestamp":1784180431000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1835351\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":35,"alternative-id":["10.3389\/fimmu.2026.1835351"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1835351","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,16]]},"article-number":"1835351"}}